Status:
COMPLETED
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
Lead Sponsor:
University of Kentucky
Collaborating Sponsors:
Pfizer
Conditions:
Methicillin-resistant Staphylococcal Aureus Pneumonia
Eligibility:
All Genders
Brief Summary
To determine the prevalence of MRSA isolates with marginal susceptibility to vancomycin or heteroresistance.
Detailed Description
Hospital acquired pneumonia (HAP) is the second-most common nosocomial infection in hospitals and the most common in the intensive care unit1. Mortality for HAP exceeds 20%2. Although mechanical venti...
Eligibility Criteria
Inclusion
- Isolates of MRSA from PAL samples
Exclusion
- None
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
1250 Patients enrolled
Trial Details
Trial ID
NCT00754273
Start Date
September 1 2008
End Date
July 1 2010
Last Update
March 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky Medical Center
Lexington, Kentucky, United States, 40536